Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension
Completed · Not applicable
Conditions studied: Anesthesia, Epidural, Hypotension
In brief
The purpose of this pilot trial is to examine the feasibility and ease of use of monitoring by ClearSight in laboring and delivering patients with the intent to compare time-to-treatment of hypotension between conventionally monitored patients (Group CM) and those receiving HPI (Group CM + HPI) monitoring by ClearSight, in a population of healthy laboring women who receive epidural analgesia.
Key facts
- Study ID
- NCT05906368
- Run by
- Grace Lim, MD, MS
- People needed
- 34
- Starts
- 2024-04-18
- Expected to finish
- 2024-08-29
- Last updated by the study team
- 2025-11-04
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Pregnant
- Age ≥ 18 years of age
- Planning vaginal delivery
- Receiving epidural labor analgesia (ELA)
You may not qualify if…
- Non-reassuring fetal tracing at the time of ELA request
- Contraindications to ELA
- Significant cardiac arrhythmias or aortic regurgitation
- Arrhythmia
- Treatment with antihypertensive medications
- Pre-eclampsia with or without severe features
- Preoperative infection
- Inability to use ClearSight device for any reason
- Non-English fluency
- Sustains unintentional dural puncture
- Incomplete data
Where it is running
- Magee Womens Hospital of UPMC — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.